ada glp 1 Dual GLP-1/GIP receptor agonist improves glycemic management and weight loss in adults living with type diabetes and obesity GLP-1 in the Spotlight: Key

Research is uncovering exciting potential benefits in other areas: Important note: These off-label or experimental uses are not yet FDA-approved

Convenience: Semaglutide GLP-1 injections are user-friendly, typically requiring once-weekly or even less frequent dosing

It is not a medicine

Heightened Sensation and Pleasure : Patients with ED, particularly those with underlying conditions such as diabetes, may experience diminished sensation and pleasure during sexual activity

If you feel great at 4mg and want to move faster, you can consider a 3-week block at the next dose instead of 4, but never skip a dose level entirely